0001593968-21-000106.txt : 20210111 0001593968-21-000106.hdr.sgml : 20210111 20210111173148 ACCESSION NUMBER: 0001593968-21-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210107 FILED AS OF DATE: 20210111 DATE AS OF CHANGE: 20210111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beebe Lydia I CENTRAL INDEX KEY: 0001635208 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36475 FILM NUMBER: 21521775 MAIL ADDRESS: STREET 1: 13403 NORTHWEST FREEWAY CITY: HOUSTON STATE: TX ZIP: 77040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEMETIS, INC CENTRAL INDEX KEY: 0000738214 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 261407544 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 BUSINESS PHONE: 408-517-3304 MAIL ADDRESS: STREET 1: 20400 STEVENS CREEK BLVD STREET 2: SUITE 700 CITY: CUPERTINO STATE: CA ZIP: 95014 FORMER COMPANY: FORMER CONFORMED NAME: AE BIOFUELS, INC. DATE OF NAME CHANGE: 20110714 FORMER COMPANY: FORMER CONFORMED NAME: AE Biofuels, Inc. DATE OF NAME CHANGE: 20071212 FORMER COMPANY: FORMER CONFORMED NAME: MARWICH II LTD DATE OF NAME CHANGE: 19840123 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2021-01-07 0000738214 AEMETIS, INC AMTX 0001635208 Beebe Lydia I 20400 STEVENS CREK BLVD, SUITE 700 CUPERTINO CA 95014 true false false false Common Stock 2021-01-07 4 A false 1300 0 A 1300 D Option (right to buy) 3.09 2021-01-07 4 A false 60000 0 A 2021-01-08 2031-01-07 Common stock and Series B Preferred 60000 60000 D RSA with Immediate vest vesting schedule Grant of Restricted Stock Awards under the Aemetis, Inc. 2019 Stock Plan to acquire 1,300 shares of the Company's Common Stock ("Option Shares") subject to the terms of the Restricted Stock Award Agreement between the Reporting Person and the Company. 100% vest Immediately Grant of Non-Qualified Incentive Stock Option under the Aemetis, Inc. 2019 Stock Plan to purchase 60,000 shares of the Company's Common Stock ("Option Shares") at an exercise price of $3.09 per share, and subject to the terms of the Stock Option Agreement between the Reporting Person and the Company. /s/Todd Waltz attorney-infact 2021-01-11